P
Petra Otterblad Olausson
Researcher at National Board of Health and Welfare
Publications - 58
Citations - 10028
Petra Otterblad Olausson is an academic researcher from National Board of Health and Welfare. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 37, co-authored 58 publications receiving 8842 citations. Previous affiliations of Petra Otterblad Olausson include Lund University.
Papers
More filters
Journal ArticleDOI
External review and validation of the Swedish national inpatient register
Jonas F. Ludvigsson,Jonas F. Ludvigsson,Eva Andersson,Anders Ekbom,Maria Feychting,Jeong-Lim Kim,Christina Reuterwall,Mona Heurgren,Petra Otterblad Olausson +8 more
TL;DR: The validity of the Swedish IPR is high for many but not all diagnoses, but for certain research areas the use of other health registers, such as the Swedish Cancer Register, may be more suitable.
Journal ArticleDOI
The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months
Björn Wettermark,Björn Wettermark,Niklas Hammar,Niklas Hammar,C. MichaelFored,Andrejs Leimanis,Petra Otterblad Olausson,Ulf Bergman,Ingemar Persson,Ingemar Persson,Anders Sundström,Barbro Westerholm,Måns Rosén +12 more
TL;DR: The content and potentials of the new Swedish national register on prescribed and dispensed medicines are described.
Journal ArticleDOI
One-year survival of extremely preterm infants after active perinatal care in sweden
Mats Blennow,Uwe Ewald,Tomas Fritz,Per Holmgren,Annika Jeppsson,Eva Lindberg,Anita Lundqvist,Solveig Lindeberg,Elisabeth Olhager,Ingrid Östlund,Marija Simic,Gunnar Sjoers,Lennart Stigson,Vineta Fellman,Lena Hellström-Westas,Mikael Norman,Magnus Westgren,Gerd Holmström,Ricardo Laurini,Karin Stjernqvist,Karin Källén,Hugo Lagercrantz,Karel Marsal,Fredrik Serenius,M Wennergren,Tore Nilstun,Petra Otterblad Olausson,Bo Strömberg +27 more
TL;DR: 1-year survival of infants born alive at 22 to 26 weeks of gestation in Sweden was 70% and ranged from 9.8% at 22 weeks to 85% at 26 weeks, and lower risk of infant death was associated with tocolytic treatment and surfactant treatment.
Journal ArticleDOI
Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
TL;DR: Use of SSRIs in early pregnancy does not seem to be a major risk factor for infant malformations, and the association between paroxetine use and infant cardiovascular defects may be a result of multiple testing, but is supported by other studies.
Journal ArticleDOI
In vitro fertilization (IVF) in Sweden: Risk for congenital malformations after different IVF methods
TL;DR: An increased risk for congenital malformations occurs after IVF, similar for the different IVF techniques used, and mainly a consequence of parental characteristics.